A competitive enzyme immunoassay was developed to detect serum complement-fixing antibodies in virus diseases. This assay utilized conglutinin-covered plastic beads as the solid phase to detect specific antibody-antigen complexes that competed for complement with a probe complex comprised of Escherichia coli beta-galactosidase and its specific antibody. Binding to the solid phase is C3bA mediated, and when specific antibody-antigen complexes are not present the probe is bound and an enzymatic reaction ensues. This type of competitive assay was introduced in the field of immunopathology for investigating circulating immune complexes by Manca et al. (Clin. Immunol. Immunopathol. 16:131-141, 1980). The assay gave satisfactory results in terms of specificity, reproducibility, and handling, enabling laboratories to obtain results in 5 h. The sensitivity of the method coincided with that of the complement fixation test. However, this technique offers several advantages over conventional complement fixation because it requires less time, is easier to perform, and gives more reliable quantitative results. The data obtained indicated that this competition assay offers a feasible alternative to conventional complement fixation tests and should be useful in routine diagnostic applications and in seroepidemiological surveys. 
A competitive enzyme immunoassay was developed to detect serum complement-fixing antibodies in virus diseases. This assay utilized conglutinin-covered plastic beads as the solid phase to detect specific antibody-antigen complexes that competed for complement with a probe complex comprised of Escherichia coli beta-galactosidase and its specific antibody. Binding to the solid phase is C3bA mediated, and when specific antibody-antigen complexes are not present the probe is bound and an enzymatic reaction ensues. This type of competitive assay was introduced in the field of immunopathology for investigating circulating immune complexes by Manca et al. (Clin. Immunol. Immunopathol. 16:131-141, 1980 ). The assay gave satisfactory results in terms of specificity, reproducibility, and handling, enabling laboratories to obtain results in 5 h. The sensitivity of the method coincided with that of the complement fixation test. However, this technique offers several advantages over conventional complement fixation because it requires less time, is easier to perform, and gives more reliable quantitative results. The data obtained indicated that this competition assay offers a feasible alternative to conventional complement fixation tests and should be useful in routine diagnostic applications and in seroepidemiological surveys. After 4 h of incubation at room temperature, the reaction mixture was centrifuged for 15 min at 7,000 x g in capillary tubes, and the supernatant fluids were tested for residual enzyme activity by a micromethod. The dilution of antibody and concentration of enzyme selected were those giving optimal formation of immune complexes (5) .
Preparation of conglutinin-covered plastic beads. Conglutinin is a large protein (700,000 molecular weight) of normal bovine serum that has affinity for C3bA bound to complement-fixing immune complexes.
Conglutinin was extracted from bovine sera and purified as precipitated euglobulin as described by Lachman (4 Antigens. Herpes simplex virus, cytomegalovirus (CMV), and varicella-zoster virus complement-fixing and negative control antigens were purchased from Behring (Scoppito, L'Aquila, Italy). Epstein-Barr virus (EBV) complement-fixing antigen was prepared from Raji cells as described by Pope et al. (6) , and EBV-negative control antigen was prepared from EBV-negative Molt lymphoblastoid cells.
Sera. We tested 112 human sera from our laboratory collection. The other sera tested and those used for correlation experiments and titration curves were control sera purchased from Behring.
Determination of optimal antigen-antibody dilution. Preliminary determinations were carried out to determine the optimal antigen and antibody dilution. Block titrations were performed to test serial dilutions of each antigen against serial dilutions of the specific control serum. The best dilution of antigen, which gave the greatest discrimination in optical density (OD) at 420 nm between the positive and negative control sera, was chosen. The same studies were done to establish the optimal serum dilution.
CEIA. To 0.1 ml of a 1:2 dilution of test serum was added 0.1 ml of the appropriate dilution of antigen. All reagents were diluted in VBS. To 0.2 ml of anti-betagalactosidase antiserum, 0.05 ml of beta-galactosidase and 0.1 ml of undiluted complement were added. After the addition of a conglutinin-covered plastic bead to each tube, the mixture was incubated at 37°C for 60 min and then at room temperature for 3 h. Beads were washed three times in VBS, and the probe complex bound was measured by adding 1 ml of ONPG. After 30 min of incubation at 37°C, the reaction was stopped by the addition of 1 ml of 0.4 M Na2CO3, and the results were read photometrically at 420 nm.
Of fundamental importance to the interpretation of the test results is the inclusion in each run of two controls, saline plus antigen and saline plus serum. DISCUSSION The serological diagnosis of viral infections has prompted intensive research into the field of enzyme immunoassay, especially the method known as ELISA (7, 8) . This paper describes a CEIA for detecting complement-fixing antibodies in human sera based on the competition of specific antibody-antigen complexes with a probe complex for binding to insolubilized conglutinin. Previously reported competitive methods in virological investigations mainly served to detect antigens reacting in competition for a limited amount of specific antibody immobilized on solid phases (6) . Antibody investigations in diagnostic virology usually employ indirect sandwich systems. The CEIA differs from the ELISA in that the enzyme is used as an antigen in a probe immune complex rather than as a covalent label of a recognizing antibody.
RESULTS
The results show that CEIA has a sensitivity practically identical to that of CF, but presents several advantages. It overcomes the variability of the hemolytic system, requires only one incubation step, and gives quantitative absorbance results. Other advantages are the stability of the reagents, the potential for automation, and the testing of only one serum dilution.
All these characteristics suggest that CEIA is a promising method for detecting complementfixing antibodies in diagnostic virology, with some theoretical and technical advantages over the techniques now in use, and that with further development and optimization this competitive immunoassay may well be used in other areas of diagnostic microbiology.
